Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06647277 · ClinicalTrials.gov registry record · Phase 1
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
A Phase 1 study, sponsored by ProgenaBiome.
- Not yet
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT06647277: Clinical Trial Phase 1 study, sponsored by ProgenaBiome.
NCT06647277 is a Phase 1 study that has not yet begun recruiting, run by ProgenaBiome. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06647277, a Phase 1 study, has not yet begun recruiting, sponsored by ProgenaBiome.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
FMT may significantly improve quality of life and Parkinson Disease (PD) symptom severity measurements. We hypothesize that gut microbial dysbiosis is a major contributing factor in Parkinson's disease.
Primary Outcome
Changes in symptoms reported
Interventions
- COMBINATION_PRODUCT Fecal Microbiota Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-12 |
| Phase | Phase 1 |
What is known before NCT06647277 opens enrollment
NCT06647277 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Fecal Microbiota Transplant is the first listed.
NCT06647277 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06647277 about?
NCT06647277 is a clinical study titled "Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease". FMT may significantly improve quality of life and Parkinson Disease (PD) symptom severity measurements. We hypothesize that gut microbial dysbiosis is a major contributing factor in Parkinson's disease.
What is the current status of trial NCT06647277?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2026-07. Estimated completion is 2027-12.
What interventions are being tested in trial NCT06647277?
The interventions under investigation include: Fecal Microbiota Transplant (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06647277?
This trial is sponsored by ProgenaBiome, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06647277's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia